(HealthDay)—The first test to screen for Severe Combined Immunodeficiency (SCID) in newborns has been approved by the U.S. Food and Drug Administration.
Clinical trials to test the new drugs in patients should begin as early as 2015.
Scientists have released details of a raft of new chemicals with potent anti-malarial properties which could open the way to new drugs to fight the disease.
Victoria University of Wellington research has identified reasons why a significant portion of heart attack patients do not respond to commonly used treatments.
An 11-year-old Mexican boy who had portions of a massive tumor removed in New Mexico is out of intensive care.
(HealthDay)—An expert advisory panel to the U.S. Food and Drug Administration decided on Tuesday not to recommend the agency issue a strong warning against the general use of steroid injections for back ...
A surge in baby boomers is driving up the number of elderly people abusing drugs or alcohol, and a New York City nursing home is trying a new approach to addressing the problem.